Medical isotope production without highly enriched uranium [electronic resource] / Committee on Medical Isotope Production Without Highly Enriched Uranium, Nuclear and Radiation Studies Board, Division of Earth and Life Studies, National Research Council of the National Academies.

Washington, D.C. : National Academies Press, c2009.

1 online resource (xviii, 202 p.)

Title from electronic title page (viewed June 1, 2009).

"This book is the product of a congressionally mandated study to examine the feasibility of eliminating the use of highly enriched uranium (HEU2) in reactor fuel, reactor targets, and medical isotope production facilities. The book focuses primarily on the use of HEU for the production of the medical isotope molybdenum-99 (Mo-99), whose decay product, technetium-99m3 (Tc-99m), is used in the majority of medical diagnostic imaging procedures in the United States, and secondarily on the use of HEU for research and test reactor fuel. The supply of Mo-99 in the U.S. is likely to be unreliable until newer production sources come online. The reliability of the current supply system is an important medical isotope concern; this book concludes that achieving a cost difference of less than 10 percent in facilities that will need to convert from HEU- to LEU-based Mo-99 production is much less important than is reliability of supply."

National Academies Press.

Print version: Washington, D.C. : National Academies Press, c2009

Books / Online

English

May 23, 2013

Includes bibliographical references.

National Research Council (U.S.). Committee on Medical Isotope Production Without Highly Enriched Uranium.